OK Biotech Co Ltd
TWSE:4155
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Changzhou Xiangming Intelligent Drive System Corporation
SZSE:301226
|
CN |
OK Biotech Co Ltd
PP&E Net
OK Biotech Co Ltd
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
OK Biotech Co Ltd
TWSE:4155
|
PP&E Net
NT$1.9B
|
CAGR 3-Years
29%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
M
|
Medtecs International Corporation Ltd
SGX:546
|
PP&E Net
$60.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Visco Vision Inc
TWSE:6782
|
PP&E Net
NT$2.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
P
|
Pegavision Corp
TWSE:6491
|
PP&E Net
NT$9.4B
|
CAGR 3-Years
20%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
SciVision Biotech Inc
TWSE:1786
|
PP&E Net
NT$1.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
11%
|
|
OK Biotech Co Ltd
Glance View
OK Biotech Co. Ltd. engages in the manufacture, wholesale, trade, and retail of medical equipment and related homecare medical products. The company is headquartered in Hsinchu, Hsinchu. The company went IPO on 2010-12-30. The firm primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The firm distributes its products principally in Taiwan, other Asian markets and the United States.
See Also
What is OK Biotech Co Ltd's PP&E Net?
PP&E Net
1.9B
TWD
Based on the financial report for Sep 30, 2025, OK Biotech Co Ltd's PP&E Net amounts to 1.9B TWD.
What is OK Biotech Co Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
25%
Over the last year, the PP&E Net growth was 27%. The average annual PP&E Net growth rates for OK Biotech Co Ltd have been 29% over the past three years , 25% over the past five years .
